BlackRock Investment Management’s Immunic IMUX Stock Holding History

BlackRock Investment Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$382K	Buy	220 +1	+0.5%	+$2.19K	﹤0.01%	3115
2016 Q3	$535K	Hold	219	–	–	﹤0.01%	3016
2016 Q2	$543K	Buy	219 +21	+11%	+$69K	﹤0.01%	3021
2016 Q1	$720K	Buy	198 +36	+22%	+$125K	﹤0.01%	2705
2015 Q4	$747K	Buy	162 +19	+13%	+$62K	﹤0.01%	2790
2015 Q3	$231K	Sell	143 -3	-2%	-$15K	﹤0.01%	3226
2015 Q2	$1.24M	Buy	146 +106	+265%	+$1.01M	﹤0.01%	2618
2015 Q1	$402K	Buy	40 +1	+3%	+$9.19K	﹤0.01%	3041
2014 Q4	$392K	Buy	39 +2	+5%	+$15.4K	﹤0.01%	3107
2014 Q3	$303K	Hold	37	–	–	﹤0.01%	3169
2014 Q2	$404K	Buy	+37	New	+$260K	﹤0.01%	3129

Other funds holding IMUX

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock Investment Management's IMUX Position: Q4 2016 in Review

BlackRock Investment Management increased its Immunic (IMUX) stake by 0.46% in Q4 2016, buying an estimated $2.19K and bringing the position to 220 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

BlackRock Investment Management first reported a position in IMUX in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.24M in Q2 2015. 55 funds tracked by Wall St. Rank hold IMUX as of Q4 2016.

BlackRock Investment Management held 220 shares of Immunic worth $382K as of Q4 2016.
BlackRock Investment Management bought 1 Immunic share in Q4 2016, an estimated $2.19K.
Immunic made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3115 holding.
BlackRock Investment Management first reported a position in Immunic in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Immunic position peaked at $1.24M in Q2 2015.
55 funds tracked by Wall St. Rank held Immunic as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.